Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Clinical trial NCT03190915 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03190915
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-09
- Primary completion
- 2023-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.